Research ArticleENDOCRINE AND DIABETES
A Novel Long-Acting Selective Neuropeptide Y2 Receptor Polyethylene Glycol-Conjugated Peptide Agonist Reduces Food Intake and Body Weight and Improves Glucose Metabolism in Rodents
Astrid A. Ortiz, Lucinda F. Milardo, Lynn B. DeCarr, Thomas M. Buckholz, Michelle R. Mays, Thomas H. Claus, James N. Livingston, Cathy D. Mahle and Kevin J. Lumb
Journal of Pharmacology and Experimental Therapeutics November 2007, 323 (2) 692-700; DOI: https://doi.org/10.1124/jpet.107.125211
Astrid A. Ortiz
Lucinda F. Milardo
Lynn B. DeCarr
Thomas M. Buckholz
Michelle R. Mays
Thomas H. Claus
James N. Livingston
Cathy D. Mahle
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleENDOCRINE AND DIABETES
A Novel Long-Acting Selective Neuropeptide Y2 Receptor Polyethylene Glycol-Conjugated Peptide Agonist Reduces Food Intake and Body Weight and Improves Glucose Metabolism in Rodents
Astrid A. Ortiz, Lucinda F. Milardo, Lynn B. DeCarr, Thomas M. Buckholz, Michelle R. Mays, Thomas H. Claus, James N. Livingston, Cathy D. Mahle and Kevin J. Lumb
Journal of Pharmacology and Experimental Therapeutics November 1, 2007, 323 (2) 692-700; DOI: https://doi.org/10.1124/jpet.107.125211
Research ArticleENDOCRINE AND DIABETES
A Novel Long-Acting Selective Neuropeptide Y2 Receptor Polyethylene Glycol-Conjugated Peptide Agonist Reduces Food Intake and Body Weight and Improves Glucose Metabolism in Rodents
Astrid A. Ortiz, Lucinda F. Milardo, Lynn B. DeCarr, Thomas M. Buckholz, Michelle R. Mays, Thomas H. Claus, James N. Livingston, Cathy D. Mahle and Kevin J. Lumb
Journal of Pharmacology and Experimental Therapeutics November 1, 2007, 323 (2) 692-700; DOI: https://doi.org/10.1124/jpet.107.125211
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement